Harvard Bioscience, Inc.
HBIO US
HBIO USHarvard Bioscience, Inc.
United States Composite2.90
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. James W. Green
- Full Time Employees
- 436
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Address
- 84 October Hill Road Holliston MA United States 01746
- IPO Date
- Mar 19, 2001
- Website
- www.harvardbioscience.com
- Business
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. The company was founded in 1901 and is based in Holliston, Massachusetts.
Company News
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
A Harvard education costs over $82,000 a year—here's how much students actually pay
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Seizing Growth Opportunities
Q1 2024 Harvard Bioscience Inc Earnings Call Transcript
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
Harvard Bioscience (HBIO) Q1 Earnings Match Estimates
Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
Harvard Bioscience Announces First Quarter 2024 Financial Results
Bruker (BRKR) Q1 Earnings Beat Estimates
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth